Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-03-08 @ 11:03 PM
Study NCT ID:
NCT01636960
Status:
TERMINATED
Last Update Posted:
2018-08-08
First Post:
2012-07-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-25
Start Date Type:
ACTUAL
Primary Completion Date:
2014-03-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-05
First Submit QC Date:
None
Study First Post Date:
2012-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-26
Results First Submit QC Date:
None
Results First Post Date:
2015-02-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-12
Last Update Post Date:
2018-08-08
Last Update Post Date Type:
ACTUAL